Bio-lab pharmaceuticals carried on a project to develop a new drug that dramatically shortened the recovery period for flu infection. the project cost the company $150,000 before bio-lab abandoned the project due to the slim possibility to gain fda approval. bio-lab then spent $300,000 on another project developing a kind of shot that achieves the same goal for flu recovery, and the company is confident in gaining fda approval for the new shot and in making profits out of the shot. what amount would be expensed?